Pharma: In the clinic
Monday, July 14, 2014
Sanofi SA, of Paris, said its Sanofi Pasteur vaccines division reported that detailed results of its first landmark phase III dengue vaccine efficacy study conducted in five countries in Asia have been published in The Lancet.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.